BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18328429)

  • 1. A conditional mouse model for malignant mesothelioma.
    Jongsma J; van Montfort E; Vooijs M; Zevenhoven J; Krimpenfort P; van der Valk M; van de Vijver M; Berns A
    Cancer Cell; 2008 Mar; 13(3):261-71. PubMed ID: 18328429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
    Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SV40 and cell cycle perturbations in malignant mesothelioma.
    Testa JR; Giordano A
    Semin Cancer Biol; 2001 Feb; 11(1):31-8. PubMed ID: 11243897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of
    Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR
    Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A spatially and temporally restricted mouse model of soft tissue sarcoma.
    Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
    Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
    Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
    Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
    Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
    Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
    Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways in malignant pleural mesothelioma.
    Whitson BA; Kratzke RA
    Cancer Lett; 2006 Aug; 239(2):183-9. PubMed ID: 16216411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
    Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.
    Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC
    Oncogene; 2003 Jun; 22(24):3799-805. PubMed ID: 12802287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities.
    Andujar P; Lecomte C; Renier A; Fleury-Feith J; Kheuang L; Daubriac J; Janin A; Jaurand MC
    Carcinogenesis; 2007 Jul; 28(7):1599-605. PubMed ID: 17272307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.
    Berg KB; Dacic S; Miller C; Cheung S; Churg A
    Arch Pathol Lab Med; 2018 Dec; 142(12):1549-1553. PubMed ID: 30059257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model recapitulating molecular features of human mesothelioma.
    Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR
    Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
    Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR
    Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.